InterAx developed a drug discovery and optimisation technology platform to go beyond target identification and ligand discovery. It is connecting AI and cell signalling to design safer and more efficacious drugs that have a precisely defined cell pathway modulation.
Products, services, technology
We are currently focusing on next-generation therapeutics for conditions with high unmet medical needs to treat several solid tumors. First in class drug molecules IAX25663 is sustainably blocking in mice the function of the target which is causing tumor growth and metastasis.
InterAx offers biopharma partners in need to gain in-depth insight for the design of high-quality drug candidates access to its technology platform.